ESR1 and metabolic disease: Given the positive association between visceral fat mass and exaggerated cardiovascular risk, the elucidation of the molecular pathway by which ERα suppresses visceral fat accumulation – and the interplay of ERα with the hormonal milieu of pregnancy, might provide insight into therapeutic strategies against metabolic disease [36].